# Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers

> **NCT01252108** · PHASE2 · WITHDRAWN · sponsor: **Sequella, Inc.**

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** SQ109

## Key facts

- **NCT ID:** NCT01252108
- **Lead sponsor:** Sequella, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2015-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252108, "Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01252108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*